An invisibility cloak for would-be cancers
by MIT Technology Review
MIT Technology Review— One of the immune system’s roles is to detect and kill cells that have acquired cancerous mutations. However, some early-stage cancer cells manage to survive. A new study on colon cancer from MIT and the Dana-Farber Cancer Institute has identified one reason why: they turn on a gene called SOX17, which renders them essentially invisible…
WION—Global impact of breast cancer | Disparities in breast cancer treatment addressed. With the estimated 2.3 million new cases of breast cancer in 2022, roughly one in every 9 cancers for both sexes diagnosed globally was breast cancer: WHO.
Axios—U.S. panel, cancer groups differ on new breast cancer screening guidelines. An influential panel lowered the recommended screening age to 40, but cancer groups say more regular screening is needed.
The Independent—Breast cancer survivors at significant risk of developing entirely new cancers, study finds. More deprived women were found to be at higher risk of lung, kidney, head and neck, bladder, oesophageal and stomach cancers